Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.

Modh, Dharti H; Modi, Siddharth J; Deokar, Hemant; Yadav, Savita; Kulkarni, Vithal M

Modh, Dharti H; Modi, Siddharth J; Deokar, Hemant; Yadav, Savita; Kulkarni, Vithal M.

Afiliação

Modh DH; Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
Modi SJ; Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
Deokar H; Department of Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Yadav S; Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
Kulkarni VM; Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.

J Biomol Struct Dyn ; 41(8): 3591-3606, 2023 05.

Article em En | MEDLINE | ID: mdl-35318898

Assuntos

Antineoplásicos; Relação Quantitativa Estrutura-Atividade; Simulação de Acoplamento Molecular; Receptores de Fatores de Crescimento de Fibroblastos; Simulação de Dinâmica Molecular; Antineoplásicos/farmacologia

Palavras-chave

3D-QSAR; FGFR; 1,6-Napthyridines; pyridopyrimidines; molecular docking and simulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relação Quantitativa Estrutura-Atividade / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google